NUVB Competitors & Alternatives
Compare Nuvation Bio Inc with similar stocks in the same industry
Biotechnology
NUVB
Main Stock$3.80
-0.26%
Tradestie Score
60
Market Cap
$1.27B
Revenue Growth
242.6%
Analyst Upside
+227.8%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
212 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$15.62
-1.01%
|
$1.43B | - | 45 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$10.08
-2.04%
|
$1.42B | - | 53 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$8.72
-4.49%
|
$1.35B | - | 61 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$23.16
-1.82%
|
$1.32B | - | 50 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.97
+2.11%
|
$1.29B | - | 37 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.81
-0.45%
|
$1.29B | - | 55 | Compare |
|
ARDX
Ardelyx, Inc.
|
$2.99
-2.29%
|
$1.29B | - | 58 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.14
-2.68%
|
$1.28B | 50.7 | 57 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
-0.21%
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
+0.82%
|
$1.22B | - | 44 | Compare |
More NUVB Analysis
Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)
212 stocks in this industry